QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.washingtonpost.com/world/2024/03/04/france-abortion-constitution/

 laidlaw--co-downgrades-evofem-biosciences-to-hold

Laidlaw & Co. analyst Yale Jen downgrades Evofem Biosciences (OTC:EVFM) from Buy to Hold.

 why-is-life-sciences-focused-aditxt-stock-trading-higher-today

Aditxt Inc (NASDAQ: ADTX) has agreed to acquire Evofem Biosciences Inc (OTC: EVFM) in consideration of the issuance of a combin...

Core News & Articles

Evofem posted $13.4 million in net sales of Phexxifor the first nine months of 2023;Aditxt looks to accelerate Evofem into the ...

 evofem-biosciences-announces-padagis-will-not-seek-fda-approval-to-market-a-generic-version-of-phexxi-until-evofems-phexxi-patents-expire

-- Padagis Determined They Will Not Challenge the Phexxi Patents --  -- Evofem Has Phexxi Patent Protection Through 2033 -- 

 evofem-biosciences-plans-1-for-125-reverse-stock-split

On Thursday May 18, 2023, the Company's common stock will open for trading under a new CUSIP (30048L302) on the OTC Venture...

Core News & Articles

-Reuters

Core News & Articles

Evofem Biosciences, Inc. (OTCQB:EVFM) today announced that Phexxi® (lactic acid, citric acid, potassium bitartrate) has been ad...

Core News & Articles

- Reuters

 benzingas-top-ratings-upgrades-downgrades-for-october-13-2022

Upgrades

 stifel-downgrades-evofem-biosciences-to-hold-lowers-price-target-to-05

Stifel analyst Annabel Samimy downgrades Evofem Biosciences (OTC:EVFM) from Buy to Hold and lowers the price target from $3 ...

 why-evofem-biosciences-shares-are-plunging-today

Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100)...

 evofem-announces-issuance-of-us-patent-covering-phexxi-composition-of-matter-newly-issued-patent-expected-to-provide-protection-for-phexxi-into-at-least-2033

-- Issuance of U.S. Patent No. 11,439,610 Further Strengthens Evofem's Intellectual Patent Portfolio -- -- Newly Issued Pa...

Core News & Articles

https://twitter.com/ZekeJMiller/status/1570831511469060096

 4-analysts-have-this-to-say-about-evofem-biosciences

  Over the past 3 months, 4 analysts have published their opinion on Evofem Biosciences (OTC:EVFM) stock. These analysts are t...

 hc-wainwright--co-maintains-buy-on-evofem-biosciences-raises-price-target-to-4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (OTC:EVFM) with a Buy and raises the price t...

 why-invitae-climbed-around-279-here-are-98-biggest-movers-from-yesterday

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION